Hydrogen-Rich Saline With Cancer Drug in Lab Lung Cancer Tests
Therapeutic efficacy of hydrogen‑rich saline alone and in combination with PI3K inhibitor in non‑small cell lung cancer
Research hubs: Respiratory System
This research was done on cells or tissue in a lab, not in people or animals.
- Evidence type
- Laboratory study (cells or tissue)
- Authors
- Yu Jiang, Gang Liu, Li Zhang, Sheng Cheng, Chun Luo, Yang Liao, Shuliang Guo
- Journal
- Molecular Medicine Reports
- Year
- 2018
- PMID
- 29901139
- Study Type
- Cell Culture
- Delivery
- Saline (Dissolved)
- Outcome
- Positive
- Peer Reviewed
- Yes
- Cited by
- 24 (OpenAlex, as of November 2026)
- Country
- China
TL;DR
A study found that treating lung cancer cells with a combination of a specific inhibitor and hydrogen-rich saline could be more effective in stopping their growth and causing them to die than using either treatment alone.
Key Finding
In lung cancer cells, combining hydrogen-rich saline with a PI3K inhibitor was more effective at stopping cell growth and triggering cell death than either treatment used separately.
Summary
Researchers tested whether hydrogen-rich saline combined with a cancer drug called LY294002 could more effectively stop lung cancer cells from growing. Using cancer cells in a lab dish, they found that the combination treatment reduced harmful molecules called free radicals (reactive oxygen species), slowed cancer cell growth, and triggered cancer cells to die—better than either treatment alone.
Practical Takeaway
This is very early laboratory research using cancer cells in a dish, not human studies or even animal testing. While the results are interesting, they do not yet indicate whether hydrogen-rich saline would help lung cancer patients. Significant additional research, including animal studies and human clinical trials, would be needed before any conclusions about real-world effectiveness could be drawn.
Abstract (excerpt)
The aim of the present study was to investigate the effects of combination therapy of LY294002, a specific inhibitor of phosphatidylinositol 3‑kinase (PI3K), with hydrogen‑rich saline on the proliferation and apoptosis of the non‑small cell lung cancer (NSCLC) A549 cell line and the mechanisms…